CALGARY, AB, March 4, 2021 /PRNewswire/ – MagicMed Industries Inc. (CSE: MGIC reserved) (“MagicMed” or the “Company“) announced today a collaboration among the Company, Dr. Suran Goonatilake and Dr. Eric Nyberg, renowned thought leaders in artificial intelligence (“AI“). Together the parties are building PsyAITM, a tool designed to provide comprehensive, pharmaceutical design, manufacturing…

Source

Previous articleSilo Pharma, Inc. Enters into an Exclusive Option Agreement with the University of Maryland, Baltimore for patented Homing Peptides Targeting Rheumatoid Arthritis
Next articlePsyBio Therapeutics Announces Retention of Market Maker